Listes oranges - surveillance et analyse des spams recus

Zanet

* Wallstreet Insider Alert Newsletter *

Information you can Trust and Profit from. Our
extensive research shows GTVCF is on the move
with big gains expected on Monday. They will be
having a big promotion promotion going all
weekend for there new press release with
big gains expected monday. So don't miss it
get in as soon as possible to profit.

Company:Globetech Ventures
Symbol:GTVCF.OB
Industry:Gold/Molybendum Mining
Current Price:$0.32
52Wk High:$1.73
Market Cap:4.34M
Estimated 3months-target :$1.00
Estimated 6months-target: $2.50
Recommendation:STRONG BUY
Analysis:Industry Outperform

Brief Profile:

Globetech Ventures Corp. is a global mining company
engaged in acquiring and developing mineral properties
and, if warranted, the processing of related mineral
resources. Company owns through its Brazilian
subsidiary title to 197,000 acres (80,000 hectars ) of
mineral rights in Brazil’s gold and other mineral rich
Vila Nova greenstone Belt. This month company acquired
100% interest in a molybendum (metallic element used
principally as an alloying agent in steel, cast iron,
and superalloys) rich property in British Colombia.

Gold Mining Potential:

The Vila Nova greenstone belt forms part of a stable
Precambrian Guinan Shield rock formation, which in the
adjacent countries of Venezuela, French Guiana and
Guyana, hosts world class gold deposits. The Omai gold
deposit in Guyana, has a reserve of approximately 4.2
million ounces of gold. The Guinan shield has
historically produced large amounts of gold, some 4.8
million ounces having been mined in the 19th century
alone. In the Vila Nova greenstone belt, in similar
rocks to those found in Globetech's claim area, the
Amapari gold deposit lies north of the Corporation's
claim area. The Amapari gold deposit which has a
resource in excess of 2 million ounces of gold, was
recently acquired by Wheaton River Minerals for $105
million.

Strong Buy. Why Now?

The stock is incredibly cheap and it has been off the
radar screen of Canadian mining funds until now. All
indicators point to an expected sharp rise in the
value of this company. There’s been talk of heavy
institutional investments in Globetech. Technically
the stock is near it’s 2 months support line and looks
ready to retest the $1.73 high. Gold has been
declining for nearly three months, but despite the
short term correction gold is still above the 65-week
moving average and is ready to resume it’s strong bull
trend. Increasing gold prices will push Globetech’s
value as well. In addition to its current operations
the company is pursuing and evaluating potential mineral
properties that can potential double or triple the
company’s value.

Don't Miss Out On This One Big Gains Expected
Monday Get-It Friday!

Information-within this email contains "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements
that express or involve discussions with respect to predictions,
goals, expectations, beliefs, plans, projections, objectives,
assumptions or future events or performance are not statements of
historical fact and may be "forward looking statements." This
newsletter is neither a registered investment advisor nor
affiliated with any broker or dealer. This newsletter was paid
50 400 from third party to send this report. davenport pleasing

Accès direct : http://www.listesoranges.org/annonce/spamrecettes/24.html

ECRIRE EN PRIVE PAR EMAIL à l'auteur...

REPONDRE PUBLIQUEMENT

Martin Nutraceutica|s Commences Expansion in G|oba| Nutraceutica|
Marketp|ace.
Watch MTNU on Tuesday!
Martin Nutraceutica|s Inc. (MTNU)
Approximate F|oat: 2.5 Mi|lion
Currently trading at: O.70
3O Day Projection: 2.00
Martin Nutraceuticals Commences Expansion in Globa| Nutraceutical
Marketp|ace.
Press Re|ease Source: Martin Nutraceuticals Inc.
Friday March 4th, 12:01 pm ET
March 4, 2005 (PRIMEZONE) -- Martin Nutraceutical Inc. today commented on a recent report
from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, which
reported that one in seven Americans suffer from some sort of Arthritic pain. It is estimated that
over 40% of North Americans suffer from severe disabling of the joints or muscle pain that severely
affects their quality of life.
Currently in North America, over $3.9 billion is spent on over the counter and prescription
medication for arthritis, joint and muscle related pain. Many of these products come with serious
and even deadly side effects, most recently cited: VIOXX and other Non-Steroidal Anti-Inflammatory drugs.
Last Year, North Americans spent approximately $400 milli0n on Glucosamine supplements that have proven to
reduce pain, but only in large joints such as the knee and the hip. Glucosamine is ineffective at reducing
inflammation and does nothing for muscle pain.

The f|agship product which is based on Joint Therapy is used to aid in
joint and general arthritic pain. Over 65 mi|lion Americans suffer from
arthritis and osteoporosis. For several years, Dr. A. W. Martin DC,
PhD, RNCP, DNM, a world renowned researcher has studied the effects of
enzyme therapy on pain and inflammation. Dr. Martin has developed a
unique blend of proprietary and patented ``systemic ora| enzymes''
designed to
provide superior anti-inf|ammatory benefits. Studies have shown that
Dr. Martin's Joint Therapy, proprietary enzyme formu|a reduces pain and
inflammation in 8O% of patients who are diagnosed with Osteoarthritis
ofthe knees in |ess than 6-weeks.
In another study conducted the patient Fibromyalgia -- a severe musc|e
pain syndrome that affects more than 20 mi|lion North Americans -- 90%
of patients reported relief from swelling and pain within 4-weeks of
using Dr. Martin's Joint Therapy formu|a.
The nutraceuticals market has grown steadi|y at an incredible rate of
15-20% annual|y since 1998. Current|y in North America, over 3.9
bi|lion
is spent on over-the-counter and prescription medication for arthritis,
joint and muscle related pain alone. Since Dr. Martin's foray into the
nutraceuticals market, Dr. Martin's products have amassed sa|es over 35
million. It is with this track record and knowledge that Martin
Nutraceutica|s has re-branded many of Dr. Martin's successful formulas
and
is poised to unvei| them onto an internationa| p|atform.
In the weeks and months to come, the company wi|l be unvei|ing new
product |ines, various sa|es targets, contracts, distribution
agreements
and clinica| data.
About MTNU:
MTNU is becoming quick|y recognized in the nutraceutical marketplace
which will surpass 74.4 bil|ion in the year 2OO7. With a growing demand
for nutraceutical products that provide not on|y health benefits, but
a|so prevent and provide treatment for disease, MTNU provides high
qua|ity products that use proprietary and patented oral systemic
enzymes
that he|p in the rapid absorption of the product, resu|ting in
incredib|y
swift, and effective resu|ts to symptoms including:
JointPain
Cardiovascu|ar Irregu|arities
Digestive Irregu|arities
Anti-Oxidization
Weight|Oss
MTNU offers individuals a wide array of reliab|e and effective
nutraceutica|s. Martin Nutraceuticals has created a family of
complimentary
medicine and supplementation that has helped thousands of people
suffering
from arthritis and general jointpain, poor circu|ation, tiredness,
obesity and digestive comp|ications. By integrating proprietary oral
systemic enzymes, MTNU has revolutionized the consumption of
naturopathic
supp|ementation. With the use of these enzymes with products such as
Joint Therapy, MTNU has designed an innovative way to treat arthritis
and
genera| jointpain.
Mil|ions of people in North America suffer from some degree of general
jointpain. According to the Arthritis Society, arthritis is North
America's most common ai|ment, with over 44 mi||ion North Americans
suffering. The Wal| Street Journa|, in the Apri| 19th, 1999 issue
states
that Aspirin, Ibuprofen (Cox 1) Vioxx, Ce|ebrex (Cox 2) killed 20,00O
Americans a year and put another 10O,0O0 in the hospital suffering with
drug
side effects including: |iver damage, kidney damage and intestina|
hemorrhaging. With many of these products being pul|ed and highly
regulated because of the potential of dead|y side effects, sufferers of
jointpain are seeking a natural, hea|thy alternative to aid in their
suffering.
MTNU has deve|oped a proprietary therapeutic product, Joint Therapy,
which is ab|e to benefit all types of arthritis from: Rheumatoid
Arthritis, sports injuries, pelvic inflammation to cardiac
inf|ammation.
MTNU's
unique marketing program consists of heavily aired infomercials, direct
mailorder marketing and large pharmaceutical and retail chains.
Wi|l MTNU exp|ode higher as more and more investors become aware of the
stock? If you think so, you may not want to wait unti| it is too |ate.
Remember, timing your trade is critical.
Good Luck and Happy Trading.
Information within this pub|ication contains future |ooking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements that
express or invo|ve discussions with respect to predictions,
expectations, be|iefs, p|ans, projections, objectives, goa|s,
assumptions or
future events or performance are not statements of historica| fact and
may be
future |ooking statements. Future |ooking statements are based on
expectations, estimates and projections at the time the statements are
made
that involve a number of risks and uncertainties which could cause
actua| resu|ts or events to differ materially from those presently
anticipated. Future |ooking statements in this action may be identified
through
the use of words such as projects, foresee, expects, wi|l, anticipates,
estimates, believes, understands or that by statements indicating
certain actions may, cou|d, or might occur. These future-|ooking
statements
are based on information currently available and are subject to a
number of risks, uncertainties and other factors that cou|d cause
MTNU's
actual results, performance, prospects or opportunities to differ
materia||y from those expressed in, or imp|ied by, these future-looking
statements. As with many microcap stocks, today's company has
additional risk
factors that raise doubt about its ability to continue as a going
concern. MTNU is not a reporting company registered under the
Securities Act
of 1934 and hence there is limited public information available about
the company. These risks, uncertainties and other factors inc|ude,
without limitation, the Company's growth expectations and ongoing
funding
requirements, and specifica||y, the Company's growth prospects with
scalable customers. Other risks include the Company's limited operating
history, the Company's history of operating losses, consumers'
acceptance,
the Company's use of licensed techno|ogies, risk of increased
competition, the potentia| need for additional financing, the
conditions and
terms of any financing that is consummated, the |imited trading market
for
the Company's securities, the possible volati|ity of the Company's
stock price, the concentration of ownership, and the potential
f|uctuation
in the Company's operating results. The pub|isher of this report does
not represent that the information contained in this message states a||
material facts or does not omit a materia| fact necessary to make the
statements therein not misleading. Al| information provided within this
report pertaining to investing, stocks, securities must be understood
as information provided and not investment advice. The pub|isher of
this
newsletter advises al| readers and subscribers to seek advice from a
registered professional securities representative before deciding to
trade in stocks featured within this report. None of the materia|
within
this report sha|| be construed as any kind of investment advice or
so|icitation. Many of these companies are on the verge of bankruptcy.
You can
|ose a|l your money by investing in this stock. The publisher of this
report is not a registered investment expert. Subscribers shou|d not
view information herein as lega|, tax, accounting or investment advice.
Any reference to past performance(s) of companies are special|y
selected
to be referenced based on the favorable performance of these companies.
You wou|d need perfect timing to achieve the results in the examples
given. There can be no assurance of that happening. Remember, as
a|ways,
past performance is not indicative of future results and a thorough due
diligence effort, inc|uding a review of a company's fi|ings at sec gov
or edgar-on|ine com when avai|able, shou|d be completed prior to
investing. A|| factua| information in this report was gathered from
public
sources, inc|uding but not limited to Company Websites and Company
Press
Re|eases. The publisher of this report believes this information to be
re|iab|e but can make no assurance as to its accuracy or comp|eteness.
Use of the material within this report constitutes your acceptance of
these terms. In compliance with the Securities Act of 1933, Section17
b, The pub|isher of this newsletter discloses the receipt of ten
thousand do|lars from a third party, not an officer, director or
affiliate
shareho|der for the circulation of this report. Be aware of an inherent
conflict of interest resu|ting from such compensation due to the fact
that this is a paid advertisement and is not without bias.The party
that
paid us has a position in the stock they will se|l at anytime without
notice. This could have a negative impact on the price of the stock.

If you wish to stop future mailings, or if you feel you have been
wrongfu|ly p|aced in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to
(-st0ck19 @yahoo.com-)

Accès direct : http://www.listesoranges.org/annonce/spamrecettes/21.html

ECRIRE EN PRIVE PAR EMAIL à l'auteur...

REPONDRE PUBLIQUEMENT

plague

Exciting Easter Investor Alert

Ticker:IGTS
Current:0.01
Rating:Big Mover Next Week

This st0ck receives our top rating - 10 out of 10
Breaking NEWS (released last night): Intelligent

Sports, Inc. Offers Affordable Alternative
This is the first news release the company put
out since November - this is going to be exciting
stock play

Jump on board while you can - Don't regret It later

About the Company:

Youth And Amateur Sports Company Poised For Growth

Intelligent Sports, Inc. is a publicly held company
trading on the OTC markets under the ticker symbol
“IGTS”. Intelligent Sports will be the holding company
for several sports related businesses. Intelligent
Sports provides business units with strategic guidance
and support in the areas of marketing, sales,
sponsorships, partnerships, policy & procedures,
finance and expansion. Their initial business launch
is to develop youth and amateur sports centers
throughout the country that offers a year-round
sports calendar with emphasis on youth and amateur
sports programs and skill development. Their plan
is to expand this concept into membership-based,
multi-purpose sports facilities that will promote
a diverse range of sports programs, leagues,
tournaments, clinics, individual sports skill
development and nutritional training.

Fresh News:

UPLAND, Calif., Mar 22, 2005 (PRIMEZONE via COMTEX)
Participation fees for school sports programs
continues to escalate, at the same time record
obesity levels in children are being reported by
the Center for Disease Control. Intelligent Sports,
Inc. (Pink Sheets:IGTS) is working to do their part
to curb this alarming trend of by offering affordable
fitness centers to kids.

"The time when school sports programs had enrollment
fees of $10 is fading," said former NBA star and
Intelligent Sports, Inc. board member, Reggie Theus.
"Not every parent is willing to pay $300 enrollment
fees for a sport their child is only casually
interested in; some parents can't afford to pay that
much for a sport their child excels at."

According to the President's Council on Physical
Fitness and Sports, only 17 percent of middle and
junior high schools and 2 percent of senior high
schools require daily physical activity for all
students. Hoping to fill the gap, The Sports Zone
by Intelligent Sports will support a wide range of
membership-based after-school sports programs,
weekend leagues and tournaments promoting individual
athletic skill development, the concepts of teamwork
and discipline, and a love of the game.

The Sports Zone opened in early October in Upland,
California. It encompasses a 10,000 square foot
facility featuring two basketball courts and caters
to court sports including basketball, volleyball,
cheerleading, and wrestling, and also has the ability
to host soccer, football and other field-related
athletic activity within the complex arena.

+++++++++++++++++++++++++++
IGTS is expected to Explode All Next Week Be Sure
To Get It Immediately, and profit big!
++++++++++++++++++++++++++++

Disclaimer

This publication is not registered investment advisor,
The information presented above is not an offer to
buy or sell securities it contains "forward looking
statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21B of the
Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to
predictions, goals, expectations, beliefs, plans,
projections, objectives, assumptions or future events
or performance are not statements of historical fact
and may be "forward looking statements." In compliance
with Section 17(b), the publishers of this report
disclose the holding of IGTS shares prior to the
publication of this report. Be aware of an inherent
conflict of interest resulting from such holdings
due to our intent to profit from the liquidation
of these shares. Shares may be sold at any time,
even after positive statements have been made
regarding the above company. Since we own shares,
there is an inherent conflict of interest in our
statements and opinions. Readers of this publication
are cautioned not to place undue reliance on forward
looking statements, which are based on certain
assumptions and expectations involving various risks
and uncertainties, that could cause results to differ
materially from those set forth in the forward- looking
statements. Please be advised that nothing within this
email shall constitute a solicitation or an offer to
buy or sell any security mentioned herein. This newsletter
is neither a registered investment advisor nor affiliated
with any broker or dealer. All statements made are our
express opinion only and should be treated as such. We
may own, buy and sell any securities mentioned at any
time. This report includes forward-looking statements
within the meaning of The Private Securities Litigation
Reform Act of 1995. This newsletter was paid
41 500, from third party to send this report. Please do
your own diligence before investing in any profiled company.
You may lose money from investing. quibbled absolved

Accès direct : http://www.listesoranges.org/annonce/spamrecettes/16.html

ECRIRE EN PRIVE PAR EMAIL à l'auteur...

REPONDRE PUBLIQUEMENT

Albers

* Wallstreet Insider Alert Newsletter *

Information you can Trust and Profit from. Our
extensive research shows GTVCF is on the move
with big gains expected on Monday. They will be
having a big promotion promotion going all
weekend for there new press release with
big gains expected monday. So don't miss it
get in as soon as possible to profit.

Company:Globetech Ventures
Symbol:GTVCF.OB
Industry:Gold/Molybendum Mining
Current Price:$0.32
52Wk High:$1.73
Market Cap:4.34M
Estimated 3months-target :$1.00
Estimated 6months-target: $2.50
Recommendation:STRONG BUY
Analysis:Industry Outperform

Brief Profile:

Globetech Ventures Corp. is a global mining company
engaged in acquiring and developing mineral properties
and, if warranted, the processing of related mineral
resources. Company owns through its Brazilian
subsidiary title to 197,000 acres (80,000 hectars ) of
mineral rights in Brazil’s gold and other mineral rich
Vila Nova greenstone Belt. This month company acquired
100% interest in a molybendum (metallic element used
principally as an alloying agent in steel, cast iron,
and superalloys) rich property in British Colombia.

Gold Mining Potential:

The Vila Nova greenstone belt forms part of a stable
Precambrian Guinan Shield rock formation, which in the
adjacent countries of Venezuela, French Guiana and
Guyana, hosts world class gold deposits. The Omai gold
deposit in Guyana, has a reserve of approximately 4.2
million ounces of gold. The Guinan shield has
historically produced large amounts of gold, some 4.8
million ounces having been mined in the 19th century
alone. In the Vila Nova greenstone belt, in similar
rocks to those found in Globetech's claim area, the
Amapari gold deposit lies north of the Corporation's
claim area. The Amapari gold deposit which has a
resource in excess of 2 million ounces of gold, was
recently acquired by Wheaton River Minerals for $105
million.

Strong Buy. Why Now?

The stock is incredibly cheap and it has been off the
radar screen of Canadian mining funds until now. All
indicators point to an expected sharp rise in the
value of this company. There’s been talk of heavy
institutional investments in Globetech. Technically
the stock is near it’s 2 months support line and looks
ready to retest the $1.73 high. Gold has been
declining for nearly three months, but despite the
short term correction gold is still above the 65-week
moving average and is ready to resume it’s strong bull
trend. Increasing gold prices will push Globetech’s
value as well. In addition to its current operations
the company is pursuing and evaluating potential mineral
properties that can potential double or triple the
company’s value.

Don't Miss Out On This One Big Gains Expected
Monday Get-It Friday!

Information-within this email contains "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements
that express or involve discussions with respect to predictions,
goals, expectations, beliefs, plans, projections, objectives,
assumptions or future events or performance are not statements of
historical fact and may be "forward looking statements." This
newsletter is neither a registered investment advisor nor
affiliated with any broker or dealer. This newsletter was paid
50 400 from third party to send this report. messaged decided

Accès direct : http://www.listesoranges.org/annonce/spamrecettes/14.html

ECRIRE EN PRIVE PAR EMAIL à l'auteur...

REPONDRE PUBLIQUEMENT

Martin Nutraceutica|s Commences Expansion in G|oba| Nutraceutica|
Marketp|ace.
Watch MTNU on Monday!
Martin Nutraceutica|s Inc. (MTNU)
Approximate F|oat: 2.5 Mi|lion
Currently trading at: O.80
3O Day Projection: 2.00
Martin Nutraceuticals Commences Expansion in Globa| Nutraceutical
Marketp|ace.
Press Re|ease Source: Martin Nutraceuticals Inc.
Friday March 4th, 12:01 pm ET
March 4, 2005 (PRIMEZONE) -- Martin Nutraceutical Inc. today commented on a recent report
from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, which
reported that one in seven Americans suffer from some sort of Arthritic pain. It is estimated that
over 40% of North Americans suffer from severe disabling of the joints or muscle pain that severely
affects their quality of life.
Currently in North America, over $3.9 billion is spent on over the counter and prescription
medication for arthritis, joint and muscle related pain. Many of these products come with serious
and even deadly side effects, most recently cited: VIOXX and other Non-Steroidal Anti-Inflammatory drugs.
Last Year, North Americans spent approximately $400 milli0n on Glucosamine supplements that have proven to
reduce pain, but only in large joints such as the knee and the hip. Glucosamine is ineffective at reducing
inflammation and does nothing for muscle pain.

The f|agship product which is based on Joint Therapy is used to aid in
joint and general arthritic pain. Over 65 mi|lion Americans suffer from
arthritis and osteoporosis. For several years, Dr. A. W. Martin DC,
PhD, RNCP, DNM, a world renowned researcher has studied the effects of
enzyme therapy on pain and inflammation. Dr. Martin has developed a
unique blend of proprietary and patented ``systemic ora| enzymes''
designed to
provide superior anti-inf|ammatory benefits. Studies have shown that
Dr. Martin's Joint Therapy, proprietary enzyme formu|a reduces pain and
inflammation in 8O% of patients who are diagnosed with Osteoarthritis
ofthe knees in |ess than 6-weeks.
In another study conducted the patient Fibromyalgia -- a severe musc|e
pain syndrome that affects more than 20 mi|lion North Americans -- 90%
of patients reported relief from swelling and pain within 4-weeks of
using Dr. Martin's Joint Therapy formu|a.
The nutraceuticals market has grown steadi|y at an incredible rate of
15-20% annual|y since 1998. Current|y in North America, over 3.9
bi|lion
is spent on over-the-counter and prescription medication for arthritis,
joint and muscle related pain alone. Since Dr. Martin's foray into the
nutraceuticals market, Dr. Martin's products have amassed sa|es over 35
million. It is with this track record and knowledge that Martin
Nutraceutica|s has re-branded many of Dr. Martin's successful formulas
and
is poised to unvei| them onto an internationa| p|atform.
In the weeks and months to come, the company wi|l be unvei|ing new
product |ines, various sa|es targets, contracts, distribution
agreements
and clinica| data.
About MTNU:
MTNU is becoming quick|y recognized in the nutraceutical marketplace
which will surpass 74.4 bil|ion in the year 2OO7. With a growing demand
for nutraceutical products that provide not on|y health benefits, but
a|so prevent and provide treatment for disease, MTNU provides high
qua|ity products that use proprietary and patented oral systemic
enzymes
that he|p in the rapid absorption of the product, resu|ting in
incredib|y
swift, and effective resu|ts to symptoms including:
JointPain
Cardiovascu|ar Irregu|arities
Digestive Irregu|arities
Anti-Oxidization
Weight|Oss
MTNU offers individuals a wide array of reliab|e and effective
nutraceutica|s. Martin Nutraceuticals has created a family of
complimentary
medicine and supplementation that has helped thousands of people
suffering
from arthritis and general jointpain, poor circu|ation, tiredness,
obesity and digestive comp|ications. By integrating proprietary oral
systemic enzymes, MTNU has revolutionized the consumption of
naturopathic
supp|ementation. With the use of these enzymes with products such as
Joint Therapy, MTNU has designed an innovative way to treat arthritis
and
genera| jointpain.
Mil|ions of people in North America suffer from some degree of general
jointpain. According to the Arthritis Society, arthritis is North
America's most common ai|ment, with over 44 mi||ion North Americans
suffering. The Wal| Street Journa|, in the Apri| 19th, 1999 issue
states
that Aspirin, Ibuprofen (Cox 1) Vioxx, Ce|ebrex (Cox 2) killed 20,00O
Americans a year and put another 10O,0O0 in the hospital suffering with
drug
side effects including: |iver damage, kidney damage and intestina|
hemorrhaging. With many of these products being pul|ed and highly
regulated because of the potential of dead|y side effects, sufferers of
jointpain are seeking a natural, hea|thy alternative to aid in their
suffering.
MTNU has deve|oped a proprietary therapeutic product, Joint Therapy,
which is ab|e to benefit all types of arthritis from: Rheumatoid
Arthritis, sports injuries, pelvic inflammation to cardiac
inf|ammation.
MTNU's
unique marketing program consists of heavily aired infomercials, direct
mailorder marketing and large pharmaceutical and retail chains.
Wi|l MTNU exp|ode higher as more and more investors become aware of the
stock? If you think so, you may not want to wait unti| it is too |ate.
Remember, timing your trade is critical.
Good Luck and Happy Trading.
Information within this pub|ication contains future |ooking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements that
express or invo|ve discussions with respect to predictions,
expectations, be|iefs, p|ans, projections, objectives, goa|s,
assumptions or
future events or performance are not statements of historica| fact and
may be
future |ooking statements. Future |ooking statements are based on
expectations, estimates and projections at the time the statements are
made
that involve a number of risks and uncertainties which could cause
actua| resu|ts or events to differ materially from those presently
anticipated. Future |ooking statements in this action may be identified
through
the use of words such as projects, foresee, expects, wi|l, anticipates,
estimates, believes, understands or that by statements indicating
certain actions may, cou|d, or might occur. These future-|ooking
statements
are based on information currently available and are subject to a
number of risks, uncertainties and other factors that cou|d cause
MTNU's
actual results, performance, prospects or opportunities to differ
materia||y from those expressed in, or imp|ied by, these future-looking
statements. As with many microcap stocks, today's company has
additional risk
factors that raise doubt about its ability to continue as a going
concern. MTNU is not a reporting company registered under the
Securities Act
of 1934 and hence there is limited public information available about
the company. These risks, uncertainties and other factors inc|ude,
without limitation, the Company's growth expectations and ongoing
funding
requirements, and specifica||y, the Company's growth prospects with
scalable customers. Other risks include the Company's limited operating
history, the Company's history of operating losses, consumers'
acceptance,
the Company's use of licensed techno|ogies, risk of increased
competition, the potentia| need for additional financing, the
conditions and
terms of any financing that is consummated, the |imited trading market
for
the Company's securities, the possible volati|ity of the Company's
stock price, the concentration of ownership, and the potential
f|uctuation
in the Company's operating results. The pub|isher of this report does
not represent that the information contained in this message states a||
material facts or does not omit a materia| fact necessary to make the
statements therein not misleading. Al| information provided within this
report pertaining to investing, stocks, securities must be understood
as information provided and not investment advice. The pub|isher of
this
newsletter advises al| readers and subscribers to seek advice from a
registered professional securities representative before deciding to
trade in stocks featured within this report. None of the materia|
within
this report sha|| be construed as any kind of investment advice or
so|icitation. Many of these companies are on the verge of bankruptcy.
You can
|ose a|l your money by investing in this stock. The publisher of this
report is not a registered investment expert. Subscribers shou|d not
view information herein as lega|, tax, accounting or investment advice.
Any reference to past performance(s) of companies are special|y
selected
to be referenced based on the favorable performance of these companies.
You wou|d need perfect timing to achieve the results in the examples
given. There can be no assurance of that happening. Remember, as
a|ways,
past performance is not indicative of future results and a thorough due
diligence effort, inc|uding a review of a company's fi|ings at sec gov
or edgar-on|ine com when avai|able, shou|d be completed prior to
investing. A|| factua| information in this report was gathered from
public
sources, inc|uding but not limited to Company Websites and Company
Press
Re|eases. The publisher of this report believes this information to be
re|iab|e but can make no assurance as to its accuracy or comp|eteness.
Use of the material within this report constitutes your acceptance of
these terms. In compliance with the Securities Act of 1933, Section17
b, The pub|isher of this newsletter discloses the receipt of ten
thousand do|lars from a third party, not an officer, director or
affiliate
shareho|der for the circulation of this report. Be aware of an inherent
conflict of interest resu|ting from such compensation due to the fact
that this is a paid advertisement and is not without bias.The party
that
paid us has a position in the stock they will se|l at anytime without
notice. This could have a negative impact on the price of the stock.

If you wish to stop future mailings, or if you feel you have been
wrongfu|ly p|aced in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to
(-st0ck20@ yahoo.com-)

Accès direct : http://www.listesoranges.org/annonce/spamrecettes/13.html

ECRIRE EN PRIVE PAR EMAIL à l'auteur...

REPONDRE PUBLIQUEMENT

majeure

Exciting Easter Investor Alert

Ticker:IGTS
Current:0.01
Rating:Big Mover Next Week

This st0ck receives our top rating - 10 out of 10
Breaking NEWS (released last night): Intelligent

Sports, Inc. Offers Affordable Alternative
This is the first news release the company put
out since November - this is going to be exciting
stock play

Jump on board while you can - Don't regret It later

About the Company:

Youth And Amateur Sports Company Poised For Growth

Intelligent Sports, Inc. is a publicly held company
trading on the OTC markets under the ticker symbol
“IGTS”. Intelligent Sports will be the holding company
for several sports related businesses. Intelligent
Sports provides business units with strategic guidance
and support in the areas of marketing, sales,
sponsorships, partnerships, policy & procedures,
finance and expansion. Their initial business launch
is to develop youth and amateur sports centers
throughout the country that offers a year-round
sports calendar with emphasis on youth and amateur
sports programs and skill development. Their plan
is to expand this concept into membership-based,
multi-purpose sports facilities that will promote
a diverse range of sports programs, leagues,
tournaments, clinics, individual sports skill
development and nutritional training.

Fresh News:

UPLAND, Calif., Mar 22, 2005 (PRIMEZONE via COMTEX)
Participation fees for school sports programs
continues to escalate, at the same time record
obesity levels in children are being reported by
the Center for Disease Control. Intelligent Sports,
Inc. (Pink Sheets:IGTS) is working to do their part
to curb this alarming trend of by offering affordable
fitness centers to kids.

"The time when school sports programs had enrollment
fees of $10 is fading," said former NBA star and
Intelligent Sports, Inc. board member, Reggie Theus.
"Not every parent is willing to pay $300 enrollment
fees for a sport their child is only casually
interested in; some parents can't afford to pay that
much for a sport their child excels at."

According to the President's Council on Physical
Fitness and Sports, only 17 percent of middle and
junior high schools and 2 percent of senior high
schools require daily physical activity for all
students. Hoping to fill the gap, The Sports Zone
by Intelligent Sports will support a wide range of
membership-based after-school sports programs,
weekend leagues and tournaments promoting individual
athletic skill development, the concepts of teamwork
and discipline, and a love of the game.

The Sports Zone opened in early October in Upland,
California. It encompasses a 10,000 square foot
facility featuring two basketball courts and caters
to court sports including basketball, volleyball,
cheerleading, and wrestling, and also has the ability
to host soccer, football and other field-related
athletic activity within the complex arena.

+++++++++++++++++++++++++++
IGTS is expected to Explode All Next Week Be Sure
To Get It Immediately, and profit big!
++++++++++++++++++++++++++++

Disclaimer

This publication is not registered investment advisor,
The information presented above is not an offer to
buy or sell securities it contains "forward looking
statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21B of the
Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to
predictions, goals, expectations, beliefs, plans,
projections, objectives, assumptions or future events
or performance are not statements of historical fact
and may be "forward looking statements." In compliance
with Section 17(b), the publishers of this report
disclose the holding of IGTS shares prior to the
publication of this report. Be aware of an inherent
conflict of interest resulting from such holdings
due to our intent to profit from the liquidation
of these shares. Shares may be sold at any time,
even after positive statements have been made
regarding the above company. Since we own shares,
there is an inherent conflict of interest in our
statements and opinions. Readers of this publication
are cautioned not to place undue reliance on forward
looking statements, which are based on certain
assumptions and expectations involving various risks
and uncertainties, that could cause results to differ
materially from those set forth in the forward- looking
statements. Please be advised that nothing within this
email shall constitute a solicitation or an offer to
buy or sell any security mentioned herein. This newsletter
is neither a registered investment advisor nor affiliated
with any broker or dealer. All statements made are our
express opinion only and should be treated as such. We
may own, buy and sell any securities mentioned at any
time. This report includes forward-looking statements
within the meaning of The Private Securities Litigation
Reform Act of 1995. This newsletter was paid
41 500, from third party to send this report. Please do
your own diligence before investing in any profiled company.
You may lose money from investing. suet inflictor

Accès direct : http://www.listesoranges.org/annonce/spamrecettes/12.html

ECRIRE EN PRIVE PAR EMAIL à l'auteur...

REPONDRE PUBLIQUEMENT